Watch CBS News

Yankees' Phil Hughes 'Anxious' To Find Cause Of Dead Arm

NEW YORK (WFAN/AP) — The Yankees are waiting for a diagnosis on injured pitcher Phil Hughes, who is scheduled for more tests Wednesday.

The right-hander had two MRIs and a vascular test to check circulation Tuesday. On the disabled list since April 15 because of a "dead arm," Hughes cut short a bullpen session Monday, saying his arm didn't feel any livelier.

"If they find something, they find something," Hughes said. "I'm just anxious to figure out what's going on."

Yankees manager Joe Girardi said the team is trying to rule out everything it possibly can, but acknowledged that Hughes could be sidelined for a while and he would be difficult to replace in the starting rotation. Girardi also defended the club's decision to skip an MRI for Hughes when he first landed on the disabled list.

"You just don't want to give guys MRIs just to give them MRIs," he said. "They say you should only have so many MRIs per year. I don't want him walking around like Spider-Man, every time you feel something you go get an MRI. I think you have to be careful. Because he had no pain, we didn't feel the need."

Hughes, 24, was 18-8 with a 4.19 ERA last year, earning his first All-Star selection. This season, he is 0-1 with a 13.94 ERA after three starts and has had trouble reaching 90 mph with his fastball.

"In the back of my mind, I'm hoping and praying that everything is okay, we're just going through a dead-arm phase," Girardi said.

How will the Yankees' rotation fare with Hughes out for an extended period? Sound off below...

(TM and Copyright 2011 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2011 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.)

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.